{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:05:59Z","timestamp":1791378359626,"version":"4.3.2"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.reprotox.2023.108473","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:42:41Z","timestamp":1695325361000},"page":"108473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Phthalates and polycystic ovary syndrome \u2013 Systematic literature review"],"prefix":"10.1016","volume":"121","author":[{"given":"Roosa","family":"Neuvonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo","family":"Huovinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Dorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1737-6066","authenticated-orcid":false,"given":"Heidi","family":"Sahlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.reprotox.2023.108473_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"issue":"Journal Article","key":"10.1016\/j.reprotox.2023.108473_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.reprotox.2023.108473_bib3","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1210\/jc.2005-2757","article-title":"Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies","volume":"91","author":"Xita","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.reprotox.2023.108473_bib4","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.reprotox.2023.108473_bib5","doi-asserted-by":"crossref","unstructured":"Dennett C.C., Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes spectrum: a publication of the American Diabetes Association. 2005;28(2):116\u2013120.","DOI":"10.2337\/diaspect.28.2.116"},{"issue":"2","key":"10.1016\/j.reprotox.2023.108473_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.17219\/acem\/59380","article-title":"The pathogenesis and treatment of polycystic ovary syndrome: What\u2019s new?","volume":"26","author":"Bednarska","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.reprotox.2023.108473_bib7","first-page":"911","article-title":"Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing","volume":"90","author":"Crain","year":"2008","journal-title":"FertilSteril"},{"issue":"Journal Article","key":"10.1016\/j.reprotox.2023.108473_bib8","first-page":"8","article-title":"The effects of phthalates on the ovary","volume":"6","author":"Hannon","year":"2015","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.reprotox.2023.108473_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11154-016-9326-7","article-title":"Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)","volume":"16","author":"Palioura","year":"2012","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"Journal Article","key":"10.1016\/j.reprotox.2023.108473_bib10","first-page":"27","article-title":"Exposure assessment issues in epidemiology studies of phthalates","volume":"85","author":"Johns","year":"2015","journal-title":"EnvironInt"},{"issue":"Journal Article","key":"10.1016\/j.reprotox.2023.108473_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jhazmat.2017.06.036","article-title":"Phthalates impact human health: Epidemiological evidences and plausible mechanism of action","volume":"340","author":"Benjamin","year":"2017","journal-title":"J. Hazard. Mater."},{"issue":"2","key":"10.1016\/j.reprotox.2023.108473_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/taap.1994.1200","article-title":"Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats","volume":"128","author":"Davis","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"18","key":"10.1016\/j.reprotox.2023.108473_bib13","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.3390\/ijerph17186811","article-title":"Effects and mechanisms of Phthalates\u2019 Action on reproductive processes and reproductive health: a literature review","volume":"17","author":"Hlisn\u00edkov\u00e1","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.reprotox.2023.108473_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2131\/jts.37.483","article-title":"Evaluation of ovarian toxicity of mono-(2-ethylhexyl) phthalate (MEHP) using cultured rat ovarian follicles","volume":"37","author":"Inada","year":"2012","journal-title":"J. Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2023.108473_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/humrep\/dev292","article-title":"Urinary phthalate metabolites and ovarian reserve among women seeking infertility care","volume":"31","author":"Messerlian","year":"2016","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.reprotox.2023.108473_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.reprotox.2012.02.006","article-title":"Reproductive effects in F1 adult females exposed in utero to moderate to high doses of mono-2-ethylhexylphthalate (MEHP)","volume":"34","author":"Moyer","year":"2012","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2023.108473_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.fertnstert.2014.05.041","article-title":"Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells","volume":"102","author":"Romani","year":"2014","journal-title":"Fertil. Steril."},{"issue":"9","key":"10.1016\/j.reprotox.2023.108473_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102788","article-title":"Sex steroid hormone levels and reproductive development of eight-year-old children following in utero and environmental exposure to phthalates","volume":"9","author":"Su","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2023.108473_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114952","article-title":"Exposure to di(2-ethylhexyl) phthalate and diisononyl phthalate during adulthood disrupts hormones and ovarian folliculogenesis throughout the prime reproductive life of the mouse","volume":"393","author":"Chiang","year":"2020","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.reprotox.2023.108473_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.reprotox.2021.09.013","article-title":"Prenatal exposure to an environmentally relevant phthalate mixture alters ovarian steroidogenesis and folliculogenesis in the F1 generation of adult female mice","volume":"106","author":"Gill","year":"2021","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.reprotox.2023.108473_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.taap.2009.10.011","article-title":"Di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro","volume":"242","author":"Gupta","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.reprotox.2023.108473_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1095\/biolreprod.115.129148","article-title":"Mono(2-ethylhexyl) phthalate accelerates early folliculogenesis and inhibits steroidogenesis in cultured mouse whole ovaries and antral follicles","volume":"92","author":"Hannon","year":"2015","journal-title":"Biol. Reprod."},{"issue":"12","key":"10.1016\/j.reprotox.2023.108473_bib23","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1177\/0300060519876467","article-title":"The effects of di(2-ethylhexyl) phthalate exposure in women with polycystic ovary syndrome undergoing in vitro fertilization","volume":"47","author":"Jin","year":"2019","journal-title":"J. Int. Med. Res."},{"issue":"Journal Article","key":"10.1016\/j.reprotox.2023.108473_bib24","article-title":"Experimental models of polycystic ovary syndrome: an update","volume":"237","author":"Divyashree","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.reprotox.2023.108473_bib25","doi-asserted-by":"crossref","unstructured":"Eden J., Levit L., Berg A., Morton S., 2011. editors. Finding What Works in Health Care: Standards for Systematic Reviews. Washington (DC); 2011.","DOI":"10.17226\/13059"},{"key":"10.1016\/j.reprotox.2023.108473_bib26","unstructured":"Higgins J., Green S. , 2011. Cochrane Handbook for Systematic Reviews of Interventions. 2011;(Journal Article). Available from: \u3008https:\/\/handbook-5\u20131.cochrane.org\/\u3009."},{"issue":"1","key":"10.1016\/j.reprotox.2023.108473_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12978-018-0469-8","article-title":"Urinary phthalate metabolites in relation to serum anti-M\u00fcllerian hormone and inhibin B levels among women from a fertility center: a retrospective analysis","volume":"15","author":"Du","year":"2018","journal-title":"Reprod. Health"},{"issue":"11","key":"10.1016\/j.reprotox.2023.108473_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019444","article-title":"The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients","volume":"99","author":"Luo","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.reprotox.2023.108473_bib29","unstructured":"Li T. ting, Xu L. zhi, Chen Y. heng, Deng H. mei, Liang C. ying, Liu Y., et al. [Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: a preliminary investigation]. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Oct;31(10):1753\u20131756."},{"issue":"12","key":"10.1016\/j.reprotox.2023.108473_bib30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1080\/09513590.2019.1630608","article-title":"Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome","volume":"35","author":"Akg\u00fcl","year":"2019","journal-title":"Gynecol. Endocrinol."},{"issue":"5","key":"10.1016\/j.reprotox.2023.108473_bib31","first-page":"1057","article-title":"Determination of serum levels of three phthalate esters in patients with polycystic ovary syndrome","volume":"6","author":"Xu","year":"2011","journal-title":"Sci. Res. Essays"},{"issue":"Pt 1","key":"10.1016\/j.reprotox.2023.108473_bib32","article-title":"The relationship between urinary phthalate metabolites and polycystic ovary syndrome in women undergoing in vitro fertilization: nested case-control study","volume":"286","author":"Al-Saleh","year":"2022","journal-title":"Chemosphere"},{"issue":"4","key":"10.1016\/j.reprotox.2023.108473_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/REP-13-0331","article-title":"The influence of antenatal exposure to phthalates on subsequent female reproductive development in adolescence: a pilot study","volume":"147","author":"Hart","year":"2013","journal-title":"Reproduction"},{"issue":"4","key":"10.1016\/j.reprotox.2023.108473_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1289\/ehp.10749","article-title":"Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples","volume":"116","author":"Adibi","year":"2008","journal-title":"Environ. Health Perspect."},{"issue":"Journal Article","key":"10.1016\/j.reprotox.2023.108473_bib35","article-title":"Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study","volume":"14","author":"Vagi","year":"2014","journal-title":"BMC Endocr. Disord."},{"issue":"4","key":"10.1016\/j.reprotox.2023.108473_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4274\/jcrpe.galenos.2020.2020.0037","article-title":"Endocrine disruptors and polycystic ovary syndrome: phthalates","volume":"12","author":"Ak\u0131n","year":"2020","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"7","key":"10.1016\/j.reprotox.2023.108473_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mnfr.200600243","article-title":"Metabolism of phthalates in humans","volume":"51","author":"Frederiksen","year":"2007","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.reprotox.2023.108473_bib38","unstructured":"European commission. Phthalates: 5. What daily exposure levels to phthalates are considered safe? [Internet]. 2008 [cited 2023 Apr 21]. Available from: \u3008https:\/\/ec.europa.eu\/health\/scientific_committees\/opinions_layman\/en\/phthalates-school-supplies\/l-2\/5-safe-daily-exposure.htm\u3009."},{"key":"10.1016\/j.reprotox.2023.108473_bib39","unstructured":"ECHA. Ftalaatit - ECHA [Internet]. 2023 [cited 2023 Apr 21]. Available from: \u3008https:\/\/echa.europa.eu\/fi\/hot-topics\/phthalates\u3009."},{"issue":"102","key":"10.1016\/j.reprotox.2023.108473_bib40","first-page":"1","article-title":"Plastic toys and child care articles as a source of children exposure to phthalates and other plasticisers in Saudi Arabia","volume":"2020","author":"Oteef","year":"2020","journal-title":"Int. J. Environ. Anal. Chem."},{"key":"10.1016\/j.reprotox.2023.108473_bib41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.scitotenv.2017.10.198","article-title":"Regulation of chemicals in children\u2019s products: How U.S. and EU regulation impacts small markets","volume":"616\u2013617","author":"Negev","year":"2018","journal-title":"Sci. Total Environ."},{"issue":"1","key":"10.1016\/j.reprotox.2023.108473_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5491\/SHAW.2011.2.1.57","article-title":"Determination of phthalate metabolites in human serum and urine as biomarkers for phthalate exposure using column-switching LC-MS\/MS","volume":"2","author":"Jeong","year":"2011","journal-title":"Saf. Health Work"},{"issue":"3","key":"10.1016\/j.reprotox.2023.108473_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/10807030902892554","article-title":"Phthalates biomarker identification and exposure estimates in a population of pregnant women","volume":"15","author":"Yan","year":"2009","journal-title":"Hum. Ecol. Risk Assess."},{"issue":"5","key":"10.1016\/j.reprotox.2023.108473_bib44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1289\/ehp.02110515","article-title":"Reproducibility of urinary phthalate metabolites in first morning urine samples","volume":"110","author":"Hoppin","year":"2002","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.reprotox.2023.108473_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01861-x","article-title":"Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood","volume":"18","author":"Tay","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.reprotox.2023.108473_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105408","article-title":"Phthalate exposure and neurodevelopment: a systematic review and meta-analysis of human epidemiological evidence","volume":"137","author":"Radke","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2023.108473_bib47","unstructured":"WHO. Obesity and overweight [Internet]. 2021 [cited 2023 Apr 21]. Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight\u3009."},{"key":"10.1016\/j.reprotox.2023.108473_bib48","unstructured":"WHO. WHO EUROPEAN REGIONAL OBESITY REPORT 2022. 2022."},{"issue":"4","key":"10.1016\/j.reprotox.2023.108473_bib49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cnur.2021.07.008","article-title":"Obesity and diabetes","volume":"56","author":"Aras","year":"2021","journal-title":"Nurs. Clin. North Am."},{"issue":"4","key":"10.1016\/j.reprotox.2023.108473_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41569-020-00465-5","article-title":"Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging","volume":"18","author":"Ng","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.reprotox.2023.108473_bib51","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/der102","article-title":"Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis","volume":"26","author":"Hickey","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2023.108473_bib52","doi-asserted-by":"crossref","DOI":"10.1159\/000375530","article-title":"The diagnosis of polycystic ovary syndrome during adolescence","author":"Witchel","year":"2015","journal-title":"Horm. Res. Paediatr."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623823001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623823001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:01:14Z","timestamp":1760191274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623823001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":52,"alternative-id":["S0890623823001478"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2023.108473","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phthalates and polycystic ovary syndrome \u2013 Systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2023.108473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108473"}}